1. Tricuspid regurgitation: pathophysiology and management
- Author
-
Jayant Nath, Rashmi Thapa, and Buddhadeb Dawn
- Subjects
Male ,medicine.medical_specialty ,Percutaneous ,New horizons ,Echocardiography, Three-Dimensional ,Guidelines as Topic ,Regurgitation (circulation) ,Cardiac Valve Annuloplasty ,Internal medicine ,Medicine ,Humans ,Minimally Invasive Surgical Procedures ,cardiovascular diseases ,Heart Valve Prosthesis Implantation ,Atrioventricular valve ,Ventricular function ,business.industry ,Treatment options ,Pathophysiology ,Tricuspid Valve Insufficiency ,Clinical Practice ,cardiovascular system ,Cardiology ,Ventricular Function, Right ,Female ,Tricuspid Valve ,Cardiology and Cardiovascular Medicine ,business - Abstract
Tricuspid regurgitation (TR) is one of the most commonly encountered valvular problems in clinical practice. Although diagnosed easily with echocardiography, it contributes to significant mortality and morbidity when severe. Once thought to be a benign functional valvular abnormality, TR has received more attention in recent years and different treatment options have emerged. However, there is no consensus regarding the superiority of one treatment approach over another. With the development of percutaneous atrioventricular valves, new horizons are open for exploration in the treatment of TR. Clinical indications of treatment are likely to change with increased use of left ventricular assist devices and increased survival of patients with poor right ventricular function. This review discusses the pathophysiology and management of TR along with newer treatment modalities currently under investigation.
- Published
- 2012